A comparison between different approaches to estimate the aqueous pK(a) values of several non-steroidal anti-inflammatory drugs

Analytica Chimica Acta

Volumn 338, Issue 1-2, 1997, Pages 127-134

  Ràfols, Clara ^a   Rosés, Martí ^a   Bosch, Elisabeth ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Arylpropionic acids; Non steroidal anti inflammatory drugs; SPARC

Indexed keywords

2 PROPANOL; ALIPHATIC CARBOXYLIC ACID; ARYLPROPIONIC ACID DERIVATIVE; BENZOIC ACID DERIVATIVE; BUTIBUFEN; CARPROFEN; DICLOFENAC; FENBUFEN; FLURBIPROFEN; IBUPROFEN; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOL DERIVATIVE; SOLVENT; TERT BUTYL ALCOHOL;

ANALYTIC METHOD; ARTICLE; CHEMICAL STRUCTURE; CONDUCTANCE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG SOLUBILITY; PKA; POTENTIOMETRY; PRIORITY JOURNAL;

EID: 0031562024     PISSN: 00032670     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-2670(96)00496-5     Document Type: Article

References (36)

1. [1] D.W. Newton and R.B. Kluza, Drug Intell. Clin. Pharm., 12 (1978) 546.
2. [2] L. Šůcha and S. Kotrlý, Solution Equilibria in Analytical Chemistry, Van Nostrand Reinhold, London, 1972.
3. [3] S.H. Hilal and S.W. Kerickhoff, Quant. Struc.-Act. Relat., 14 (1995) 348.
4. [4] J. Barbosa, J. Sánchez and E. Bosch, Talanta, 31 (1984) 279.
5. [5] E. Bosch, C. Ràfols and M. Rosés, Talanta, 36 (1989) 1277.
6. [6] R.M. Fuoss and C.A. Kraus, J. Am. Chem. Soc., 55 (1933) 4769.
7. [7] R.M. Fuoss, J. Am. Chem. Soc., 57 (1935) 488.
8. [8] R.M. Fuoss and T. Shedlovsky, J. Am. Chem. Soc., 71 (1949) 1469.
9. [9] H.S. Harned and B.B. Owen, The Physical Chemistry of Electrolytic Solutions, 3rd edn., Reinhold, New York, 1958.
10. [10] E. Bosch and M. Rosés, Talanta, 36 (1989) 627.
11. [11] M. Rosés, M.J. Bonet and E. Bosch, Anal. Chim. Acta, 333 (1996) 241.
12. [12] G. Akerlov, J. Am. Chem. Soc., 54 (1932) 4125.
13. [13] M. Sakurai, J. Sol. Chem., 17 (1988) 267.
14. [14] K. Soliman and E. Marschall, J. Chem. Eng. Data., 35 (1990) 375.
15. [15] M. Rosés, Anal. Chim. Acta, 276 (1993) 211.
16. [16] E. Bosch and M. Rosés, Talanta, 36 (1989) 615.
17. [17] E. Bosch and M. Rosés, Talanta, 36 (1989) 623.
18. [18] M.K. Chantooni and I.M. Kolthoff, Anal. Chem., 51 (1979) 133.
19. [19] E. Bosch, C. Rodés and M. Rosés, Electroanalysis, 3 (1991) 365.
20. [20] M.J. Kamlet, J.L.M. Abboud, M.H. Abraham and R.W. Taft, J. Org. Chem., 48 (1983) 2877.
21. [21] N.S. Isaacs, Physical Organic Chemistry, Longman Scientific and Technical, London, 1992.
22. [22] IUPAC Dissociation Constants of Organic Acids in Aqueous Solution, 1961.
23. [23] The Merck Index, 12th edn., Merck, Whitehouse Station, NJ, 1996.
24. [24] A. Fini, P. De Maria, A. Guarnieri and L. Varoli, J. Pharm. Sci., 76 (1987) 48.
25. [25] E. Bosch, C. Ràfols and M. Rosés, Anal. Chim. Acta, 302 (1995) 109.
26. [26] C.D. Herzfeld and R. Kümel, Drug Develop. Ind. Pharm., 9 (1983) 546.
27. [27] Y. Maitani, A. Coutel-Egros, Y. Obata and T. Nagai, J. Pharm. Sci., 82 (1993) 416.
28. [28] G.N. Valsami, P.E. Macheras and M.A. Koupparis, Analyst, 114 (1989) 387.
29. [29] D.W. Newton and R.B. Kluza, Drug Intelligence and Industrial Pharmacy, 9 (1983) 767.
30. [30] M.S. Kislaliuglu, M.A. Khan, C. Blount, R.W. Goettsch and S. Bolton, J. Pharm. Sci., 80 (1991) 799.
31. [31] The British Pharmacopoeia HMSO, London, 1993.
32. [32] The Martindale Extra Pharmacopeia, 31st edn., The Pharmaceutical Press, London, 1993.
33. [33] US Pharmacopeia, 23rd edn., 1995, United States Pharmacopeial Convention, Rockville, MD, 1994.
34. [34] US Pharmacopeia 23rd edn., 1995, United States Pharmacopeial Dispensing Information, Vol III, Approved Drug Products and Legal Requirements, Rockville, MD, 1994.
35. [35] L.J. Davis, Drug Intell. Clin. Pharm., 9 (1975) 501.
36. [36] A. Chiarini and A. Tartarini, Arch. Pharm. (Weinheim), 317 (1984) 268.